NCT00002907View on ClinicalTrials.gov

Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 1997

Primary Completion Date

January 31, 1999

Study Completion Date

November 30, 2000

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
DRUG

bryostatin 1

Trial Locations (1)

48201

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00002907 - Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma | Biotech Hunter | Biotech Hunter